Yarom, Noam http://orcid.org/0000-0001-9771-7857
,
Hovan, Allan
Bossi, Paolo
Ariyawardana, Anura
Jensen, Siri Beier
Gobbo, Margherita
Saca-Hazboun, Hanan
Kandwal, Abhishek
Majorana, Alessandra
Ottaviani, Giulia
Pentenero, Monica
Nasr, Narmin Mohammed
Rouleau, Tanya
Lucas, Anna Skripnik
Treister, Nathaniel Simon
Zur, Eyal
Ranna, Vinisha
Vaddi, Anusha
Barasch, Andrei
Lalla, Rajesh V
Cheng, Karis Kin Fong
Elad, Sharon
Article History
Received: 4 October 2019
Accepted: 18 December 2019
First Online: 13 February 2020
Compliance with ethical standards
:
: Per MASCC Guidelines Policy, employees of commercial entities were not eligible to serve on this MASCC Guidelines Panel.The authors disclose no conflict of interest (NY, AH, AA, SBJ, MG, HIH, AK, AM, JO, MP, NMN, TR, ASL, NST, EZ, VR, AV, KF, AB). PB has served an advisory role for AstraZeneca, Helsinn, and Kyowa Kyrin and received grants from Merck, Kyowa Kyrin, and Roche. RVL has served as a consultant for Colgate Oral Pharmaceuticals, Galera Therapeutics, Ingalfarma SA, Monopar Therapeutics, Mundipharma, and Sucampo Pharma; has received research support to his institution from Galera Therapeutics, Novartis, Oragenics, and Sucampo Pharma; and has received stock in Logic Biosciences. SE discloses no conflict of interest in regards to the subject matter, and served as a consultant for Falk Pharma outside the submitted work.